Repurposing Licensed Drugs with Activity Against Epstein-Barr Virus for Treatment of Multiple Sclerosis: A Systematic Approach. - Li V; McKay FC; Tscharke DC; Smith C; Khanna R; Lechner-Scott J; Rawlinson WD; Lloyd AR; Taylor BV; Morahan JM; Steinman L; Giovannoni G; et al. (CNS drugs, 2025)